Application of CBNAAT (Xpert MTB/RIF assay) in new smear negative pulmonary tuberculosis patients
Presumptive pulmonary tuberculosis (PTB) patients whose sputum are detected to be smear negative for acid fast bacilli (AFB) present a significant challenge for a treating physician. Initiating these patients on anti tuberculous treatment (ATT) on empirical basis is not a good strategy as many were...
Main Authors: | Vishal Chopra, Baljeet Singh Virk, Siddharth Chopra, Monika Bansal, Jain Chungath |
---|---|
Format: | Article |
Language: | English |
Published: |
PAGEPress Publications
2020-02-01
|
Series: | Monaldi Archives for Chest Disease |
Subjects: | |
Online Access: | https://www.monaldi-archives.org/index.php/macd/article/view/1146 |
Similar Items
-
Increased detection of smear-negative pulmonary tuberculosis by GeneXpert MTB/RIF® assay after bleach concentration
by: Mulualem Tadesse, et al.
Published: (2016-01-01) -
Impact of Larger Sputum Volume on Xpert® MTB/RIF Assay Detection of Mycobacterium tuberculosis in Smear-Negative Individuals with Suspected Tuberculosis
by: Sharlaa Badal-Faesen, et al.
Published: (2017-08-01) -
Cerebrospinal fluid Gene XPERT (CBNAAT) in children with tuberculous meningitis
by: Annapurna Rai, et al.
Published: (2021-08-01) -
Tuberculosis treatment outcomes among people living with HIV diagnosed using Xpert MTB/RIF versus sputum-smear microscopy in Botswana: a stepped-wedge cluster randomised trial
by: Tefera Agizew, et al.
Published: (2019-12-01) -
Use of Xpert MTB/RIF for diagnosis of pediatric tuberculosis in Indonesia
by: Rina Triasih, et al.
Published: (2020-07-01)